Cushing’s Disease : Sustained Remission in Five Cases Induced by Medical Therapy with the Dopamine Agonist Cabergoline = مرض كوشينج : الإستجابة الكاملة و المستمرة للعلاج بواسطة عقار الكابرجولين
نویسندگان
چکیده
منابع مشابه
Medical Treatment in Cushings Syndrome: Dopamine Agonists and Cabergoline
Dopamine (DA) is a catecholamine with a wide range of functions and whose five subtype receptors are found in different organs where they exert a mainly inhibitory action. Since this action may also appear in a number of secretory tumors in various locations, DA agonists have elicited some interest as a medical treatment for hypercorticism. Non-iatrogenic Cushing’s syndromes are due in 70% of t...
متن کاملMedical Treatment in Cushings Syndrome: Dopamine Agonists and Cabergoline
Dopamine (DA) is a catecholamine with a wide range of functions and whose five subtype receptors are found in different organs where they exert a mainly inhibitory action. Since this action may also appear in a number of secretory tumors in various locations, DA agonists have elicited some interest as a medical treatment for hypercorticism. Non-iatrogenic Cushing’s syndromes are due in 70% of t...
متن کاملRemission with Cabergoline in Adolescent Boys with Cushing’s Disease
Cabergoline is a long-acting dopamine receptor agonist used for treatment of patients with uncured Cushing's disease (CD) and, as a first-line treatment, was used in only limited numbers of patients. This report presents two adolescent boys with CD who were treated with cabergoline. Two adolescent boys with clinical and laboratory findings of CD are presented. No pituitary adenoma was detected ...
متن کاملDopamine Agonist Therapy in Advanced Parkinson’s Disease
“Parkinson’s disease (PD) doesn’t kill you, it takes your life away.” This is a disturbing quotation by the English Parkinson Lay Organisation. There is, however, no other neurodegenerative disease which responds better to treatment than PD. Treatment of advanced PD is located between these poles (Figure 1). Most national guidelines and papers on the treatment of PD recommended that early phase...
متن کاملCabergoline in acromegaly: a renewed role for dopamine agonist treatment?
OBJECTIVE AND DESIGN Eighteen active acromegalics entered a prospective open study with cabergoline (CAB), a dopaminergic drug much more potent than bromocriptine (Br). METHODS CAB was administered for 6 months at doses ranging between 0.5 mg twice weekly and 0.5 mg/day. Clinical-anamnestic characteristics of the patients were: (i) sensitivity to dopamine agonist drugs (10 patients); (ii) res...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Sultan Qaboos University Medical Journal
سال: 2012
ISSN: 2075-0528
DOI: 10.12816/0003176